Anti- Dermatophytic Activity of Codiaeum Variegatum (L.) Rumph Ex A. Juss and Byrsocarpus Coccineus Schum. And Thonn. Leaf Extract

References

[1] Adebayo, E. A., & Ishola, O. R. (2009). Phytochemical and antimicrobial screening of Byrsocarpus coccineus Schumach. and Thonn. Journal of Medicinal Plants Research, 3(3), 107–112.

[2] Ahmad, I., Mehmood, Z., & Mohammad, F. (2019). Screening of some Indian medicinal plants for their antimicrobial properties. Journal of Ethnopharmacology, 62(2), 183–193.

[3] Ajaiyeoba, E. O., Onocha, P. A., & Farombi, O. E. (2020). Pharmacognostic standardization and antimicrobial evaluation of Byrsocarpus coccineus Schum. & Thonn. (Connaraceae). African Journal of Traditional, Complementary and Alternative Medicines, 17(1), 123–131.

[4] Ajibesin, K. K., Ekpo, B. A., Bala, D. N., Essien, E. E., & Adesanya, S. A. (2008). Ethnobotanical survey of Akwa Ibom State of Nigeria. Journal of Ethnopharmacology, 115(3), 387–408.

[5] Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016). Methods for in vitro evaluating antimicrobial activity: A review. Journal of Pharmaceutical Analysis, 6(2), 71–79.

[6] Bhatia, N., & Kalele, K. (2024). Dermatophytosis: Epidemiology, clinical features, and impact on quality of life. Journal of Clinical Dermatology and Therapy, 12(4), 221–229.

[7] Cowan, M. M. (1999). Plant products as antimicrobial agents. Clinical Microbiology Reviews, 12(4), 564–582.

[8] Denning, D. W., & Bromley, M. J. (2015). How to bolster the antifungal pipeline. Science, 347(6229), 1414–1416.

[9] Gupta, A. K., & Singh, A. (2020). Dermatophytosis: Epidemiology, pathogenesis, and management. Indian Journal of Dermatology, 65(5), 356–365.

[10] Olajide, O. A., Akinmoladun, F. O., & Farombi, E. O. (2021). Phytochemical and antimicrobial studies of Codiaeum variegatum leaves. Journal of Medicinal Plants Research, 15(7), 256–264.

[11] Shambel, A., Enyew, E. F., Gizachew, M., & Tsegaye, T. (2020). Dermatophytosis: A review of epidemiology, clinical manifestations, diagnosis, and treatment. Journal of Mycology, 7974261.

[12] Singh, A., & Verma, P. (2025). Antifungal resistance mechanisms in dermatophytosis: Genetic mutations and clinical implications. Clinical Mycology Reviews, 15(2), 85–99.

[13] Sofowora, A., Ogunbodede, E., & Onayade, A. (2013). The role and place of medicinal plants in the strategies for disease prevention. African Journal of Traditional, Complementary and Alternative Medicines, 10(5), 210–229.

[14] Verma, S. B., & Singal, A. (2023). Steroid abuse in dermatophytosis: Clinical consequences and management challenges. Indian Journal of Dermatology, 68(2), 98–104.

[15] Weitzman, I., & Summerbell, R. C. (1995). The dermatophytes. Clinical Microbiology Reviews, 8(2), 240–259.

@article{1714373,
      author = {Olufunke Christy Akanji, Timileyin Toluwani Olobaniyi},
      title = {Anti- Dermatophytic Activity of Codiaeum Variegatum (L.) Rumph Ex A. Juss and Byrsocarpus Coccineus Schum. And Thonn. Leaf Extract},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {8},
      pages = {1383-1387},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1714373.pdf},
      abstract = {Dermatophytic infections remain a major public health concern, particularly in tropical and subtropical regions, due to increasing resistance, cost, and adverse effects associated with conventional antifungal agents. This study evaluated the in vitro antidermatophytic activity of ethanol leaf extracts of Codiaeum variegatum and Byrsocarpus coccineus against selected dermatophytes. The antifungal activity was assessed using the agar well diffusion method against Microsporum canis, Trichophyton rubrum, and Epidermophyton floccosum at concentrations of 50, 25, and 12.5 mg/ml. Chloramphenicol (5 mg/ml) served as the positive control. The ethanol extract of C. variegatum exhibited marked antidermatophytic activity against all test organisms, with M. canis showing the highest susceptibility. Zones of inhibition ranged from 18 to 60 mm, with notable activity observed at lower extract concentrations. The leaf extract of B. coccineus also demonstrated appreciable antifungal activity, although with comparatively lower inhibitory effects. Its highest zones of inhibition was recorded against E. floccosum at 12.5 mg/ml (40 mm). The observed antifungal activities are attributed to the presence of bioactive phytoconstituents such as flavonoids, tannins, saponins, and phenolic compounds. These findings support the ethnomedicinal use of both plants in the management of fungal skin infections and highlight their potential as sources of novel antidermatophytic agents.},
      keywords = {Codiaeum Variegatum; Byrsocarpus Coccineus; Dermatophytes; Antidermatophytic Activity; Medicinal Plants; Antifungal Agents.},
      month = {February},
      doi = {https://doi.org/10.64388/IREV9I8-1714373}
  }